Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...
Q4 2024 Earnings Call Transcript February 20, 2025 Repligen Corporation beats earnings expectations. Reported EPS is $0.44, ...
Fascinating new research shows mollusk blood proteins have strong antimicrobial properties, especially when combined with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback